CASI Pharmeceuticals

View All

CASI Pharmaceuticals CEO Ken K. Ren, PhD rang the closing bell at NASDAQ on Thursday, June 11, 2015 4PM. Click the link below to access NASDAQ’s video archive to view the ceremony. http://www.nasdaq.com/marketsite/marketsite-events-detail.aspx?fn=201506-close06112015.txt

CASI Pharmaceuticals, Inc. to Ring the Nasdaq Stock Market Closing Bell Thursday, June 11, 2015

About Us

A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.

Learn More

In the News

EntreMed leverages best of China and the West and seeks to expand pipeline.

Read Article →

Poster

Phase II Study of Oral ENMD-2076 Administered to Patients (pts) With Advanced Soft Tissue Sarcoma

Download →

Poster

Phase II Study of Oral ENMD-2076 Administered to Patients with Ovarian Clear Cell Carcinoma

Download →

Receive press releases via email